InterAct Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-07-21.
InterAct Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 21, 2026. The filing reports $250K sold. Its industry group is Other Health Care. It names Daniel Hargrove (Mr. Hargrove is the CEO and a director of the Issuer.), Isaac Chan (Dr. Chan is a director of the Issuer) (SEC Form D, July 21, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like InterAct Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-07-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns InterAct Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind InterAct Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in Texas, filed in July 2026, largest first.
Get an email when InterAct Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when InterAct Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch InterAct Therapeutics, Inc. →Get the full cited report on InterAct Therapeutics, Inc.
What the filing shows about InterAct Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on InterAct Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives InterAct Therapeutics, Inc.'s address as 3060 Pegasus Park Drive, Building 6, Dallas, TX 75247.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on InterAct Therapeutics, Inc. See pricing
InterAct Therapeutics, Inc. is a registered filer with the SEC (CIK 2107143) and has filed since 2026-07-21. 1 filing is on record, the latest on 2026-07-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
InterAct Therapeutics, Inc.'s Form D of 2026-07-21 names Daniel Hargrove and Isaac Chan as its officers, directors or promoters.
Its new offerings report $250K sold across 1 offering, as its own filings state.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Daniel Hargrove is named as Mr. Hargrove is the Ceo and a director of the Issuer. on the Form D that InterAct Therapeutics, Inc. filed with the SEC on 21 July 2026, one of 2 people that filing names.
On the filing as: Director.
Isaac Chan is named as Dr. Chan is a director of the Issuer on the Form D that InterAct Therapeutics, Inc. filed with the SEC on 21 July 2026, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2026-07-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about InterAct Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on InterAct Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on InterAct Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist InterAct Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind InterAct Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for InterAct Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises, week of 2026-07-20 · Health care raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/interact-therapeutics-inc-form-d-26000001